Introduction
Chocolate is recognized as a type of food that contains many psychoactive components (cannabinoid-like molecules, methylxanthines, long-chain carboxylic acids, and other factors) which activate the serotonergic system of the prefrontal cortex and, more importantly, the dopaminergic system, for short periods of time [1] . Many studies have shown that some people may present compulsive symptoms such as difficulty in resisting the urge to consume chocolate [2] . There is, therefore, similarity between this condition and the craving that happens in substance dependence.
Many neural pathways are involved in craving, especially serotoninergic, dopaminergic and opioidergic, derived from several cortical areas (prefrontal cortex, amygdala and hippocampus) [3, 4] . There are still no specific treatments for these symptoms.
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There are two molecular families in the PUFAs classification: omega 3 and omega 6 fatty acids. Through a series of chemical reactions, alpha linolenic acid is transformed into either docosahexaenoic acid (DHA) or eicosapentaenoic (EPA) -both omega 3 fatty acids. Another PUFA is the linoleic acid that generates arachidonic acid (AA) -omega 6 fatty acids. Omega 6 fatty acids is pro-inflammatory, pro-thrombotic and seems to contribute to drug addiction and relapse, and omega 3 fatty acids inhibit these same processes, acting as antagonists of omega 6 fatty acids [5] .
Flaxseed oil is rich in alpha-linolenic acid, the main precursor of omega 3 fatty acids and linoleic acid, rich in omega 6. This combination determined our choice to administer flaxseed oil, since it contains both omega 6 and omega 3, in the ratio 4:1, even though several studies suggest the ideal ingestion ranging from 3:1 up to 5:1 [10] .
Therefore, the objective of this study was to determine if daily dietary supplementation with flaxseed oil might successfully mitigate chocolate consumption and craving.
Methodology
This is a double blind, placebo-controlled, randomized trial. The inclusion criteria were: both genders; age between 18 and 45 years; BMI between 18.5 and 25, and binge eating scale (BES) score greater than 18. The exclusion criteria were: volunteers diagnosed with any psychiatric disorder (according to DSM-IV-TR criteria) and those taking any psychoactive medication, or using any recreational drugs. The Beck Depression Inventory and the Beck Anxiety Inventory [11] were also applied. Any volunteer classified as moderately depressed or anxious according to their score in those instruments was excluded.
Our initial sample consisted of 29 females (mean age 30 years old). Four volunteers dropped out of the study for personal reasons, not related to the experiment itself, such as side effects of the flaxseed oil or any other difficulties. Therefore, our final sample was of 25 volunteers (N = 25).
The volunteers considered eligible filled the BES, informed the amount of chocolate (g/day) ingested before and after two months of treatment. Additionally, they provided blood samples on the same occasions.
We assigned them to two groups: the placebo group received capsules containing a formula of paraffin and # 2 dye, simulating the visual aspect of fatty acids, and the experimental group received capsules containing 1000 mg of flaxseed oil, in the proportion of 4:1 of omega 6 and omega 3, respectively. The intervention lasted two months. Volunteers were instructed to take one capsule three times a day, and not to modify their regular diet during the study.
In order to obtain objective data about craving symptoms, we used the binge eating scale (BES), originally developed by Gormally et al. [12] and translated into Portuguese by Freitas et al. [13] . The instrument evaluated three aspects: typical behavioral manifestations (shame and social isolation), subjective feelings in regard to daily consumption of chocolate, and frequency and amount of chocolate consumption. Every question was multiplechoice and self-reported, presenting 3 to 4 different alternatives each. Total scores evaluated different states: scores lower than 17 were correlated with minimal or non-existent chocolate craving; scores between 18 and 26-regarded moderate craving, and scores higher than 27 indicated severe craving.
In order to assess the PUFAs (EPA, DHA, AA and Linoleic acid) levels of participants, we utilized the high performance liquid chromatography (HPLC) technique, dosed at baseline in blood samples of the volunteers and after two months of supplementation. The quantification protocol of PUFAs dosage was performed according to Abushufa in 1994 [14] using the HPLC. Briefly, total lipids were extracted from plasma, using water-chloroform-methanol [15] . Fatty acids were prepared with 4-bromomethyl-7-coumarin and then separated on a Shimadzu LC-10A high performance liquid chromatograph using an octa-decylsilica column (25 cm × 4.6 mm i.d.; particle size 5 mm). Fatty acids were resolved using a mobile phase of acetonitrile-water (85:15 vol/vol) at a flow rate of 1.5 ml/ min. Fatty acid derivatives were detected by fluorescence (325-nm excitation; 395-nm emission).
The project was approved by the committee of ethics in research under registration number 0695/10. We obtained informed consent form from all participants.
Statistical Analyses
We analyzed data with ANOVA for repeated measures and Newman-Keuls post-hoc test (for measurements in the omega 3 group -BES score between both groups at the beginning and end of study). Data from the laboratorial analyses were paired with BES scores using Pearson's correlation. The other data concerning group characteristics -initial BMI, Beck anxiety and depression scores, Chocolate daily consumption -between the groups in both measurements were compared using t Student test. The level of significance was p < 0.05 for all analyses. Table 1 shows the comparison between the placebo (n = 14) and the experimental (n = 11) groups, before and after the treatment. There were no statistically significant differences, before the intervention, between the placebo and experimental groups concerning the following parameters: educational level, body mass index, anxiety, depression and initial BES scores.
Results
After the two-month trial period, there was a significant difference between the BES scores of the experimental and placebo groups (ANOVA for repeated measures: F 1,24 = 111.878; p < 0.001). In the experimental group, there was a significant difference between the BES scores before and after treatment (post hoc Newman-Keuls p < 0.001) (Figure 1 ).
The consumption of chocolate was also different between groups after treatment. The ANOVA pointed to a significant effect of time (F 1,24 = 15.207; p < 0.001), and group (F 1,24 = 15.589; p < 0.001). According to the post-hoc test, the experimental group significantly reduced chocolate consumption after treatment (p < 0.001), while the placebo group kept a similar mean consumption (p > 0.05) ( Table 2 ).
The fatty acid profile established by the HPLC method was analyzed, and there was a significant difference in the DHA levels between groups (F 1,16 = 5.4963; p < 0.05). The Newman-Keuls posthoc test showed an increase of DHA in the experimental group after supplementation for two months (p < 0.05). The mean percentage of DHA in the experimental group increased from 3.45% in the pretreatment to 4.75% in the post-treatment. The other dosages did not show significant variations in either group (Table 3) .
When data from BES scores were paired with the fatty acid fractions obtained, a strong negative correlation was observed between the amounts of DHA in the experimental group (DHA 1) in the beginning of the experiment and the initial BES score (BES 1). The results showed that the participants most affected were the ones who presented lower concentrations of DHA fatty acids (Pearson correlation = -0.66). This correlation was practically eliminated in the analysis after two months of intervention (DHA 2 and BES 2), thus indicating the participants were no longer characterized as persons craving for chocolate. Additionally, fatty acid levels were normalized (Pearson correlation = 0,17). There was a negative correlation between the increasing EPA levels and the BES scores after the intervention in the experimental group (Pearson correlation = -0.57), suggesting that this component also helps reduce craving symptoms. There were no clear significant correlations in the placebo group.
Discussion
The results of this study showed that the participants who ingested flaxseed oil (3,000 mg/day) for two months presented lower scores in the binge eating scale (BES) after intervention. One possible explanation for these findings could be the role of omega 3 in regulating the functioning of the dopaminergic systems [16] . Some studies show that omega 3 deficiency results in a dopaminergic hypofunctioning of the mesocortical and mesolimbic pathways related to reinforcing effects [5, 6] . Therefore, our results would suggest that there was a regulation of dopamine neurotransmission and the consequent reduction of craving for chocolate. However, we should bear in mind that flaxseed oil contains two forms of PUFAs (Omega 6 and Omega 3) in a ratio close to that recommended for a healthy diet which, according to several studies, should be 3:1 and 5:1, respectively [10] .
Studies employing functional magnetic resonance imaging (fMRI) detected that stimulation by chocolate enhances the brain activities of the reward systems comprised by areas such as the striatum, the medial orbitofrontal cortex and the cingulate gyrus [17] .
Several researches demonstrated that those brain areas can also be activated by a number of highly palatable foods [18] [19] [20] [21] . The same might happen with stimuli of other natures, notably music, painting and monetary rewards [22] [23] [24] [25] .
It is widely recognized that the brain regions related to reward mechanisms are mediated by dopaminergic pathways through the release of dopamine from the ventral tegmental area into their terminals in the nucleus accumbens and striatum [26] .
Another aspect to be highlighted regards the correlation between the reduction in the BES and the increase in the blood levels of DHA. In other words, the supplementation with omega 3 played an important role in reducing craving for chocolate. Some studies assert that this craving increases when people stop ingesting that omega, remaining for about two weeks [27] . Increased levels of anxiety are also observed under those circumstances [28, 29] . They can increase even further when the individuals are exposed to smell or images of chocolate [30, 31] .
Finally, high performance liquid chromatography (HPLC) detected higher concentrations of DHA-fraction of omega 3 only in the group which received flaxseed oil. Consequently, we can conclude that the experimental group ingested the capsules regularly, and that the placebo group followed the instruction not to change their diet during the period of the study. Even though our sample was small, the results seem to be promising to mitigate chocolate craving and consumption. 
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